Downloads : Remote device and disease management: the need for change
| Author | J.M. Morgan, Southampton (GB) |
|---|---|
| Title | Remote device and disease management: the need for change |
| Shownotes | The phenomenon of growing implantation rates all over the world, with varying rates across Europe, is predicated and driven by the strong clinical evidence coming from studies like MADIT, COMPANION, SCD-HeFT and CARE-HF. These studies show a significant reduction in sudden cardiac death when using Implantable Cardioverter Defibrillators (ICDs) and they show the efficacy of Cardiac Resynchronization Therapy (CRT) for heart failure patients. This creates a bigger burden when following up these patients with an increasingly complex clinical scenario and with the challenge of qualified staff constraints. The options available to the European healthcare system suggest that only the adoption of new technologies can help respond to the current challenges, justifying "the need for change". |